Maternal serum adiponectin at 11-13 weeks of gestation in pregnancies delivering small for gestation neonates

Fetal Diagnosis and Therapy

Volumn 29, Issue 4, 2011, Pages 274-279

  Nanda, Surabhi ^a   Akolekar, Ranjit ^a   Sodre, Danielle ^a,b   Vaikousi, Eirini ^a,b   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Adiponectin; Fetal growth restriction; First trimester; Pregnancy associated plasma protein A; Small for gestational age

Indexed keywords

ADIPONECTIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; PLACENTA FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RACE DIFFERENCE; SMALL FOR DATE INFANT;

ADIPONECTIN; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REGRESSION ANALYSIS;

EID: 79959317090     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000323327     Document Type: Article

References (39)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749.
2. Mazaki-Tovi S, Kanety H, Sivan E: Adiponectin and human pregnancy. Curr Diab Rep 2005;5:278-281. (Pubitemid 41269592)
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
4. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599. (Pubitemid 30353893)
5. Briana DD, Malamitsi-Puchner A: The role of adipocytokines in fetal growth. Ann NY Acad Sci 2010;1205:82-87.
6. Street ME, Volta C, Ziveri MA, Viani I, Bernasconi S: Markers of insulin sensitivity in placentas and cord serum of intrauterine growth-restricted newborns. Clin Endocrinol 2009;71:394-399.
7. Kyriakakou M, Malamitsi-Puchner A, Militsi H, Boutsikou T, Margeli A, Hassiakos D, Kanaka-Gantenbein C, Papassotiriou I, Mastorakos G: Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers. Eur J Endocrinol 2008;158:343-348. (Pubitemid 351404998)
8. Kamoda T, Saitoh H, Saito M, Sugiura M, Matsui A: Serum adiponectin concentrations in newborn infants in early postnatal life. Pediatr Res 2004;56:690-693. (Pubitemid 39403391)
9. Cianfarani S, Martinez C, Maiorana A, Scirè G, Spadoni GL, Boemi S: Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth. J Clin Endocrinol Metab 2004;89:1346-1351. (Pubitemid 38368435)
10. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH: Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn 2011;31:58-65.
11. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-346. (Pubitemid 28352196)
12. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH: Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free β-human chorionic gonadotropin, and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-624.
13. Nanda S, Yu CKH, Giurcaneanu L, Akolekar R, Nicolaides KH: Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsia. Fetal Diagn Ther DOI: 10.1159/000322402.
14. Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH: Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11-13 weeks. Prenat Diagn DOI:10.1002/pd.2636.
15. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH: First-trimester screening for trisomy 21 by free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008;31:493-502.
16. Fuglsang J, Skjaerbaek C, Frystyk J, Flyvbjerg A, Ovesen P: A longitudinal study of serum adiponectin during normal pregnancy. BJOG 2006;113:110-113.
17. Fasshauer M, Bluher M, Stumvoll M, Tonessen P, Faber R, Stepan H: Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol 2007;66:434-439. (Pubitemid 46239304)
18. Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N: Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci (Lond) 2008;115:219-224.
19. Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, Dong Z, Yoon BH, Hassan SS, Kusanovic JP: Maternal serum adiponectin multimers in patients with a small-for-gestational- age newborn. J Perinat Med 2009;37:623-635.
20. Meral C, Cekmez F, Pirgon O, Asya Tanju I, Metin Ipcioglu O, Karademir F, Gocmen I: The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth. J Matern Fetal Neonatal Med 2011; 24: 166-170.
21. Martínez-Cordero C, Amador-Licona N, Guízar-Mendoza JM, Hernández-Méndez J, Ruelas-Orozco G: Body fat at birth and cord blood levels of insulin, adiponectin, leptin, and insulin-like growth factor-I in small-for-gestational-age infants. Arch Med Res 2006;37:490-494.
22. Takaya J, Yamato F, Higashino H, Kaneko K: Intracellular magnesium and adipokines in umbilical cord plasma and infant birth size. Pediatr Res 2007;62:700-703. (Pubitemid 350158809)
23. Ibáñez L, Sebastiani G, López-Bermejo A, Díaz M, Gómez-Roig MD, de Zegher F: Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab 2008;93:2774-2778. (Pubitemid 352008550)
24. López-Bermejo A, Casano-Sancho P, Fernández-Real JM, Kihara S, Funahashi T, Rodríguez-Hierro F, Ricart W, Ibañez L: Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin. Clin Endocrinol (Oxf) 2004;61:339-346.
25. Evagelidou EN, Giapros VI, Challa AS, Kiortsis DN, Tsatsoulis AA, Andronikou SK: Serum adiponectin levels, insulin resistance, and lipid profile in children born small for gestational age are affected by the severity of growth retardation at birth. Eur J Endocrinol 2007;156:271-277. (Pubitemid 46554523)
26. Sancakli O, Darendeliler F, Bas F, Gokcay G, Disci R, Aki S, Eskiyurt N: Insulin, adiponectin, IGFBP-1 levels and body composition in small for gestational age born nonobese children during prepubertal ages. Clin Endocrinol (Oxf) 2008;69:88-92. (Pubitemid 351847257)
27. Pardo IM, Geloneze B, Tambascia MA, Barros- Filho AA: Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight. Obes Res 2004;12:521-524. (Pubitemid 41132532)
28. Sivan E, Mazaki-Tovi S, Pariente C, Efraty Y, Schiff E, Hemi R, Kanety H: Adiponectin in human cord blood: relation to fetal birth weight and gender. Clin Endocrinol Metab 2003;88:5656-5660. (Pubitemid 38033030)
29. Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y: Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol (Oxf) 2004;61:418-423. (Pubitemid 39388478)
30. Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho SC, Chu CH: Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clin Endocrinol (Oxf) 2004;61:88-93.
31. Inami I, Okada T, Fujita H, Makimoto M, Hosono S, Minato M, Takahashi S, Harada K, Yamamoto T: Impact of serum adiponectin concentration on birth size and early postnatal growth. Pediatr Res 2007;61:604-606. (Pubitemid 46650015)
32. Verhaeghe J, van Bree R, Van Herck E: Maternal body size and birth weight: can insulin or adipokines do better? Metabolism 2006;55:339-344.
33. Ong GK, Hamilton JK, Sermer M, Connelly PW, Maguire G, Zinman B, Hanley AJ, Retnakaran R: Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution. Clin Endocrinol (Oxf) 2007;67:108-114. (Pubitemid 46955449)
34. Lévy-Marchal C, Czernichow P: Small for gestational age and the metabolic syndrome: which mechanism is suggested by epidemiological and clinical studies? Horm Res 2006;65:123-130.
35. Varvarigou AA: Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metab 2010;23:215-224.
36. Nicolaides KH: Turning the pyramid of prenatal care. Fetal Diagn Ther 2011 (in press).
37. Lindqvist PG, Molin J: Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 2005;25:258-264.
38. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. A meta-analysis. Obstet Gynecol 2010;116:402-414.
39. Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH: Prediction of small for gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther DOI:10.1159/000321694.